Vapers Digest 28th September
Monday’s News at a glance:
South Africa Embraces Evidence ~ When Falling Youth Tobacco Use Becomes Another Crisis Story ~ The Question Vaping Policy Keeps Avoiding: What Happens to Smoking? ~ Smoking history is key to understanding Chronic Disease burden among people who vape ~ US Fast-Tracks Vapes. Asia Bans Them. Same Science, Opposite Rules ~ Dear Senate: If You Want to Hear From Canadians, You Have to Let Canadians Speak ~ FDA Reportedly Plans Major PMTA Overhaul ~ Prisons Turn to Vaping for Harm Reduction as Ireland Debates Tougher Restrictions ~ NAS 2026 | Cliff Douglas: Risk Continuum Should Play a Central Role in Tobacco Policy ~ NAS 2026 | FDA CTP Director Says PMTA Pathway Is “Predicated on Tobacco Harm Reduction” ~ NAS 2026 | Former FDA Tobacco Chief Mitch Zeller Calls for Shift From “End Game” to “End State” ~ Decisive Move | Haypp Goes All-In on U.S. Nicotine Pouch Market | RegWatch ~ What are nicotine pouches?
South Africa Embraces Evidence
Dave Cross, Planet Of The Vapes
South Africa’s Portfolio Committee on Health has voted to advance the ‘Tobacco Products and Electronic Delivery Systems Control Bill,’ with members signalling support for an evidence-based regulatory approach that distinguishes between combustible and non-combustible nicotine products based on relative risk.
Two From Alan Gor
When Falling Youth Tobacco Use Becomes Another Crisis Story
There is something revealing about the way tobacco-control data are sometimes presented. When the numbers move in the wrong direction, they are treated as evidence of failure, but when the numbers move in the right direction, they can still somehow be presented as a warning that failure is just around the corner. Stanton Glantz’s new paper in Paediatrics, using the 2025 National Youth Tobacco Survey, is a good example. The headline finding should be encouraging: tobacco use among US middle and high school students continued to fall in 2025, reaching 7.2%.
The Question Vaping Policy Keeps Avoiding: What Happens to Smoking?
For years, the youth vaping debate has been framed around a simple objective: reduce vaping. On the surface, that sounds entirely reasonable. Nobody wants young people who have never smoked taking up nicotine unnecessarily, and sensible policies should protect them. But there is a problem with judging policy by one number alone: what if a policy reduces vaping but increases cigarette smoking? That question matters because cigarettes and e-cigarettes are not remotely equivalent in risk, and a new working paper by Christopher Lowenstein, Jamie Hartmann-Boyce and Michael Pesko goes directly to that issue.
Smoking history is key to understanding Chronic Disease burden among people who vape
Center of Excellence for the acceleration of Harm Reduction
A new CoEHAR population-based study of more than 7,600 adults in England highlights why smoking history is essential when interpreting chronic disease among people who use e-cigarettes.
Published in the Journal of Epidemiology and Population Health, the study analysed data from 7,625 adults participating in the 2022 Health Survey for England. Researchers compared chronic disease and multimorbidity across six groups, importantly distinguishing e-cigarette users who had never smoked from those who had previously smoked cigarettes.
US Fast-Tracks Vapes. Asia Bans Them. Same Science, Opposite Rules
Coalition of Asia Pacific Tobacco Harm Reduction Advocates (CAPHRA)
The United States is preparing to fast-track approvals for vapes and nicotine pouches. Across Asia-Pacific, governments are banning, seizing and prosecuting the same products, says the Coalition of Asia Pacific Tobacco Harm Reduction Advocates (CAPHRA).
The US Food and Drug Administration is expected to announce within days that it will revisit its 2021 rules for new tobacco product applications. Officials reportedly aim to simplify study requirements and shorten review times, using legal alternatives to push illicit products out of the market.
Dear Senate: If You Want to Hear From Canadians, You Have to Let Canadians Speak
The Nicotine Project
I learned a lot about the Senate of Canada this past week. Mostly, I learned that we talk an awful lot about the lived experience for a system that makes it pretty damn difficult for those with it to actually participate.
For years, I have encouraged Canadians to get involved in government. Write. Call. Make submissions. Speak up and speak out. I believe politicians need to hear from us, and I believe ordinary Canadians can change things when enough of us make noise.
Timothy S. Donahue, Nicotine Insider
The FDA may be preparing to rewrite the PMTA playbook.
The U.S. Food and Drug Administration is expected to announce measures in the coming days to expedite the authorization of e-cigarettes, nicotine pouches, and other tobacco products, potentially including a review of the agency’s 2021 final rule governing premarket tobacco product applications (PMTAs).

Prisons Turn to Vaping for Harm Reduction as Ireland Debates Tougher Restrictions
Diane Caruana, Vaping Post
As Ireland considers increasingly restrictive vaping policies, including comments from Taoiseach Micheál Martin supporting a potential ban, officials inside the country’s prison system are examining whether controlled vaping could help solve a very different public-health problem: exposure to cigarette smoke.
Three From 2Firsts
NAS 2026 | Cliff Douglas: Risk Continuum Should Play a Central Role in Tobacco Policy
Cliff Douglas, principal of Tobacco Control Law & Policy Consulting, called for the continuum of risk across tobacco and nicotine products to play a central role in tobacco policy, arguing that the next stage of tobacco control should focus more directly on reducing exposure to combustion and accelerating the displacement of combustible cigarettes.
NAS 2026 | FDA CTP Director Says PMTA Pathway Is “Predicated on Tobacco Harm Reduction”
Bret Koplow, director of the U.S. Food and Drug Administration’s Center for Tobacco Products (CTP), said the premarket tobacco product application (PMTA) pathway is “predicated on tobacco harm reduction,” as he outlined the agency’s approach to building a regulated marketplace that protects youth while giving adults who smoke access to lower-risk alternatives.
NAS 2026 | Former FDA Tobacco Chief Mitch Zeller Calls for Shift From “End Game” to “End State”
The 2026 New Approaches Summit was held Friday at the Harvard Club of New York City under the theme “Saving Lives in the 21st Century.” The meeting brings together participants from public health, regulation, science and industry to discuss tobacco control and harm reduction. 2Firsts is reporting from the event.
Decisive Move | Haypp Goes All-In on U.S. Nicotine Pouch Market | RegWatch
Brent Stafford, Regulator Watch
America’s nicotine pouch market is booming. With millions of adults already using lower-risk nicotine products and tens of millions more still smoking, Haypp Group is going all-in on the United States.
In Part 3 of our RegWatch special series on nicotine pouches in America, Gabriel De Prado, President of Haypp’s U.S. Market, explains why the world’s leading online retailer of nicotine pouches is dramatically expanding its American operations and why the company believes online sales can become the trusted channel for adult consumers.
What are nicotine pouches?
Global State of Tobacco Harm Reduction (GSTHR)
Shops worldwide are now stocking small, round containers of nicotine pouches. But many people don’t know much about these new products. What’s in them? How are they used? Are they just as harmful as smoking? The Global State of Tobacco Harm Reduction’s new video explainer has got you covered.
On this day…2022!
A look back at how things have moved on or otherwise…
Alex Norcia, Filter Magazine
A new paper published in the Journal of Health Economics suggests that burdensome taxes on vaping products lead to an increase in cigarette sales.
The tobacco epidemic is growing in India
Shantanu Guha Ray, The Times Of India
E-cigarettes and harm-reduction products continue to remain banned for almost three years in India, while legal sales of cigarettes, bidis and other tobacco-based products continue.
Visit Nicotine Science & Policy for more News from around the World








